公开(公告)号：US20200044159A1

公开(公告)日：2020-02-06

申请号：US16523168

申请日：2019-07-26

Applicant: SAMSUNG DISPLAY CO., LTD.

Inventor： Akinori YAMATANI

IPC: H01L51/00 ,  C07F5/02 ,  C09K11/02 ,  C07D471/04 ,  C07F7/10 ,  C07F9/6571 ,  C07D497/14 ,  C09K11/06

Abstract: An organic electroluminescence device includes a first electrode, a hole transport region on the first electrode, an emission layer on the hole transport region, the emission layer including a condensed polycyclic compound of three or more six-membered rings, at least two six-membered rings among the six-membered rings including an electron donor moiety and an electron acceptor moiety at facing positions, respectively, the at least two six-membered rings not being immediately adjacent to each other, an electron transport region on the emission layer, and a second electrode on the electron transport region.

公开(公告)号：US10270043B2

公开(公告)日：2019-04-23

申请号：US15274062

申请日：2016-09-23

Applicant: FUJIFILM Corporation ,  The University of Tokyo

Inventor： Hiroaki Tsuyama ,  Kimiatsu Nomura ,  Yoshihisa Usami ,  Eiji Fukuzaki ,  Masashi Koyanagi ,  Tetsu Kitamura ,  Tetsuya Watanabe ,  Toshihiro Okamoto ,  Junichi Takeya

IPC: H01L51/00 ,  C07D493/14 ,  C07D495/14 ,  C07D497/14 ,  C07D513/14 ,  C07D517/14 ,  C07D519/00 ,  C09D5/24 ,  C09B57/00 ,  H01L51/05

Abstract: Provided are an organic transistor with high carrier mobility having a semiconductor active layer containing a compound which is represented by the following formula and has a molecular weight of equal to or less than 3,000, a compound, an organic semiconductor material for a non-light-emitting organic semiconductor device, a material for an organic transistor, a coating solution for a non-light-emitting organic semiconductor device, a method for manufacturing an organic transistor, a method for manufacturing an organic semiconductor film, an organic semiconductor film for a non-light-emitting organic semiconductor device, and a method for manufacturing an organic semiconductor material. (X represents an oxygen, sulfur, selenium, or tellurium atom or NR5; Y and Z each represents CR6, an oxygen, sulfur, selenium, or nitrogen atom, or NR7; a ring containing Y and Z is an aromatic heterocycle; any one of R1 and R2 and the aromatic heterocycle containing Y and Z or any one of R3 and R4 and a benzene ring may be bonded to each other through a specific divalent linking group; R1, R2, and R5 to R8 each represent a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, or a heteroaryl group; R3 and R4 each represent an alkyl group, an alkenyl group, an alkynyl group, an aryl group, or heteroaryl group; and each of m and n is an integer of 0 to 2).

公开(公告)号：US10995101B2

公开(公告)日：2021-05-04

申请号：US16354022

申请日：2019-03-14

Applicant: iTeos Therapeutics SA

Inventor： Stefano Crosignani ,  Bruno Gomes ,  Erica Houthuys

IPC: C07D513/14 ,  C07D497/14 ,  A61P35/00

Abstract: The present invention relates to compounds of Formula I or pharmaceutically acceptable salts or solvates thereof. The invention further relates to the use of the compounds of Formula I as A2A inhibitors. The invention also relates to the use of the compounds of Formula I for the treatment and/or prevention of cancer. The invention also relates to a process for manufacturing compounds of Formula I.

公开(公告)号：US10608185B2

公开(公告)日：2020-03-31

申请号：US15483032

申请日：2017-04-10

Applicant: Universal Display Corporation

Inventor： Chi Hang Lee ,  Raymond Kwong

IPC: H01L51/00 ,  H01L51/50 ,  C09K11/06 ,  C09K11/02 ,  C07C13/62 ,  C07D409/14 ,  C07D403/04 ,  C07D409/10 ,  C07D493/04 ,  C07D491/147 ,  C07D407/10 ,  C07D497/04 ,  C07D221/18 ,  C07D411/14 ,  C07D401/04 ,  C07D403/14 ,  C07D241/38 ,  C07D471/04 ,  C07D403/10 ,  C07D498/04 ,  C07D411/04 ,  C07D471/14 ,  C07D209/86 ,  C07D413/04 ,  C07D409/04 ,  C07D401/14 ,  C07D405/04 ,  C07D405/14 ,  C07D497/14 ,  C07D311/78 ,  C07D265/34 ,  C07D307/91 ,  C07D413/14 ,  C07D491/052 ,  C07D498/14 ,  C07D327/06 ,  C07D491/048

Abstract: The present invention includes fused tetraphenylene compounds that may be used as charge transporters, hosts or emitters in OLEDs.

公开(公告)号：US20040048854A1

公开(公告)日：2004-03-11

申请号：US10449643

申请日：2003-05-30

Inventor： Hiren V. Patel ,  Anup K. Ray ,  Pramod B. Patel ,  Mahendra R. Patel

IPC: A61K031/551 ,  C07D497/14

CPC classification number: C07D495/04

Abstract: A process for the preparation of polymorph Form I of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thienonull2,3-bnullnull1,5null benzodiazepine, or olanzapine.

Abstract translation: 制备2-甲基-4-（4-甲基-1-哌嗪基）-10H-噻吩并[2,3-b] [1,5]苯并二氮杂或奥氮平的多晶型I的方法。

公开(公告)号：US5393751A

公开(公告)日：1995-02-28

申请号：US595287

申请日：1990-10-10

Applicant: Michiyuki Sendai ,  Tetsuo Miwa

Inventor： Michiyuki Sendai ,  Tetsuo Miwa

IPC: C07D487/04 ,  A61K31/397 ,  A61K31/40 ,  A61P31/04 ,  C07D471/14 ,  C07D477/00 ,  C07D487/14 ,  C07D491/14 ,  C07D491/147 ,  C07D495/14 ,  C07D497/14 ,  C07F7/18 ,  C07D487/00 ,  A01N43/00 ,  A61K31/395

CPC classification number: C07D477/00 ,  C07D471/14 ,  C07D491/14 ,  C07D495/14 ,  C07D497/14 ,  C07F7/186

Abstract: A compound of the formula ##STR1## wherein R.sup.1 is a hydrogen atom or a hydrocarbon group which may be substituted; COOR.sup.2 represents a carboxy group which may be esterified; and ring B is a cyclic group which may be substituted or a pharmaceutically acceptable salt thereof are useful as an antibacterial agent.

Abstract translation: 式（I）的化合物，其中R 1是氢原子或可被取代的烃基; COOR2表示可被酯化的羧基; 并且环B是可被取代的环状基团或其药学上可接受的盐可用作抗菌剂。

公开(公告)号：US11912672B2

公开(公告)日：2024-02-27

申请号：US17052933

申请日：2019-07-12

Applicant: SOLUS ADVANCED MATERIALS CO., LTD.

Inventor： Hyungchan Bae ,  Young Bae Kim ,  Hoe Moon Kim ,  Ho Jun Son ,  Jin Woong Kim

IPC: C07D251/24 ,  C07D495/14 ,  C07D497/14 ,  H10K85/60 ,  H10K50/12

CPC classification number: C07D251/24 ,  C07D495/14 ,  C07D497/14 ,  H10K85/622 ,  H10K85/654 ,  H10K85/6574 ,  H10K85/6576 ,  H10K50/12

Abstract: A novel compound having excellent light emission and heat stability is disclosed. Also disclosed is an organic electroluminescent device having properties such as light emitting efficiency, an operation voltage, and a service life improved by including the compound in at least one organic layer of the device.

公开(公告)号：US20210198281A1

公开(公告)日：2021-07-01

申请号：US16993897

申请日：2020-08-14

Applicant: iTeos Therapeutics SA

Inventor： Stefano Crosignani ,  Bruno Gomes ,  Erica Houthuys

IPC: C07D513/14 ,  A61P35/00 ,  C07D497/14

Abstract: The present invention relates to compounds of Formula I or pharmaceutically acceptable salts or solvates thereof. The invention further relates to the use of the compounds of Formula I as A2A inhibitors. The invention also relates to the use of the compounds of Formula I for the treatment and/or prevention of cancer. The invention also relates to a process for manufacturing compounds of Formula I.

公开(公告)号：US09062064B2

公开(公告)日：2015-06-23

申请号：US13139658

申请日：2009-12-14

Applicant: Olaf Zeika ,  Horst Hartmann ,  Ulrich Heggemann ,  Sascha Dorok ,  Jan Blochwitz-Nimoth ,  Ansgar Werner ,  Michael Hofmann ,  Carsten Rothe

Inventor： Olaf Zeika ,  Horst Hartmann ,  Ulrich Heggemann ,  Sascha Dorok ,  Jan Blochwitz-Nimoth ,  Ansgar Werner ,  Michael Hofmann ,  Carsten Rothe

IPC: H01B1/00 ,  C07D327/06 ,  C07D497/04 ,  C07D497/14 ,  C07D497/22 ,  C09K11/06 ,  H01L51/00 ,  H05B33/10

CPC classification number: C07D497/04 ,  C07D497/14 ,  C07D497/22 ,  C09K11/06 ,  C09K2211/1011 ,  C09K2211/1088 ,  C09K2211/1096 ,  H01B1/00 ,  H01L51/0071 ,  H05B33/10 ,  Y02E10/549 ,  Y02P70/521

Abstract: The present invention relates to the use of heterocyclic compounds as the charge transport material, blocker material or light-scattering material in electronic, optoelectronic or electroluminescent components.

Abstract translation: 本发明涉及杂环化合物在电子，光电子或电致发光组分中作为电荷传输材料，阻挡材料或光散射材料的用途。

公开(公告)号：US20080090817A1

公开(公告)日：2008-04-17

申请号：US11951097

申请日：2007-12-05

Applicant: Simeon Bowers ,  Albert Garofalo ,  Roy Hom ,  Andrei Konradi ,  Matthew Mattson ,  Martin Neitzel ,  Christopher Semko ,  Anh Truong ,  Jing Wu ,  Ying-zi Xu

Inventor： Simeon Bowers ,  Albert Garofalo ,  Roy Hom ,  Andrei Konradi ,  Matthew Mattson ,  Martin Neitzel ,  Christopher Semko ,  Anh Truong ,  Jing Wu ,  Ying-zi Xu

IPC: A61K31/5365 ,  A61K31/437 ,  A61P25/28 ,  C07D497/04 ,  C07D497/14 ,  C07D471/14 ,  A61K31/4985

CPC classification number: C07D451/14 ,  C07D471/08 ,  C07D471/18 ,  C07D471/22 ,  C07D498/08

Abstract: The invention provides N-cyclic sulfonamido compounds and salts of Formula I: wherein A is as described in the specification and R1 and R2 combine to form a [3.3.1] or a [3.2.1] ring system, where the nitrogen is attached to the two bridgehead carbons, and the [3.3.1] or [3.2.1] ring systems are optionally fused with an heteroaryl or heterocycloalkyl ring. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula I, methods of treating cognitive disorders, such as Alzheimer's disease, and the intermediates useful in preparing the compounds of Formula I.

Abstract translation: 本发明提供N-环磺酰氨基化合物和式I的盐：其中A如说明书中所述，R 1和R 2 2结合形成[3.3.1 ]或[3.2.1]环体系，其中氮连接到两个桥头堡碳上，并且[3.3.1]或[3.2.1]环体系任选地与杂芳基或杂环烷基环稠合。 式I的化合物可用于治疗或预防认知障碍，例如阿尔茨海默病。 本发明还包括含有式I化合物的药物组合物，治疗认知障碍的方法，例如阿尔茨海默氏病，以及可用于制备式I化合物的中间体。